Take a fresh look at your lifestyle.

Oryzon reduces its losses by 7.7% in 2020 to 3.4 million euros


Oryzon went through the confessional this Monday. The biotech company has declared losses of 3.4 million euros in 2020, a figure that represents a reduction of 7.7% compared to the same period of the previous year.

The company has reported research and development expenses of 1.6 million recognized directly against losses.


Leave A Reply

Your email address will not be published.